The account alleges that on (b)(6) 2016, the patient complained of blindness after embolization of a meningioma via the left middle meningeal artery.The patient's left central retinal artery occlusion was diagnosed on the basis of ophthalmologic evaluation performed after completion of the embolization procedure.The physician administered solu-medrol (iv, 1000 mg/day) and radicut (iv, 60 mg/day) until (b)(6) 2016.On (b)(6) 2016, the physician administered tandetron (iv, 80 mg/day) as well.On (b)(6) 2016, the patient was transferred to another hospital where she received hyperbaric oxygen therapy until (b)(6) 2016.On (b)(6) 2016, the patient was transferred to the reporter's hospital again to undergo craniotomy for meningioma, as treatment for blindness in the acute phase had been completed.On (b)(6) 2017, resection of meningioma was performed.On (b)(6) 2017, no change was noted in blindness in the left eye, and the patient was discharged home.
|